MORF INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Morphic Holding, Inc. and Encourages Stockholders to Contact the Firm!Accesswire • 08/02/24
Eli Lilly's tirzepatide injection results could trigger another bull run: Here's whyInvezz • 08/01/24
Lilly CEO says weight-loss drug shortage to end 'very soon', Bloomberg News reportsReuters • 08/01/24
Eli Lilly (LLY) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseZacks Investment Research • 08/01/24
MORF STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Morphic Holding, Inc. and Encourages Shareholders to Contact the Firm!Accesswire • 08/01/24
Eli Lilly says tirzepatide showed positive results in late-stage trial evaluating it as treatment for heart failureMarket Watch • 08/01/24
Lilly's tirzepatide successful in phase 3 study showing benefit in adults with heart failure with preserved ejection fraction and obesityPRNewsWire • 08/01/24
Here is What to Know Beyond Why Eli Lilly and Company (LLY) is a Trending StockZacks Investment Research • 07/31/24
MORF SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Morphic Holding, Inc. and Encourages Shareholders to Contact the Firm!Accesswire • 07/31/24
MORF INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Morphic Holding, Inc. and Encourages Shareholders to Contact the Firm!Accesswire • 07/30/24